These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
277 related articles for article (PubMed ID: 12424609)
1. Cytosine deaminase and thymidine kinase gene therapy in a Dunning rat prostate tumour model: absence of bystander effects and characterisation of 5-fluorocytosine metabolism with 19F-NMR spectroscopy. Corban-Wilhelm H; Hull WE; Becker G; Bauder-Wüst U; Greulich D; Debus J Gene Ther; 2002 Dec; 9(23):1564-75. PubMed ID: 12424609 [TBL] [Abstract][Full Text] [Related]
2. Cytosine deaminase versus thymidine kinase: a comparison of the antitumor activity. Corban-Wilhelm H; Becker G; Bauder-Wüst U; Greulich D; Debus J Clin Exp Med; 2003 Nov; 3(3):150-6. PubMed ID: 14648229 [TBL] [Abstract][Full Text] [Related]
3. Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-flucytosine. Lawrence TS; Rehemtulla A; Ng EY; Wilson M; Trosko JE; Stetson PL Cancer Res; 1998 Jun; 58(12):2588-93. PubMed ID: 9635583 [TBL] [Abstract][Full Text] [Related]
4. Enzyme/prodrug gene therapy: comparison of cytosine deaminase/5-fluorocytosine versus thymidine kinase/ganciclovir enzyme/prodrug systems in a human colorectal carcinoma cell line. Trinh QT; Austin EA; Murray DM; Knick VC; Huber BE Cancer Res; 1995 Nov; 55(21):4808-12. PubMed ID: 7585511 [TBL] [Abstract][Full Text] [Related]
5. Comparison of different methods to assess the cytotoxic effects of cytosine deaminase and thymidine kinase gene therapy. Corban-Wilhelm H; Ehemann V; Becker G; Greulich D; Braun K; Debus J Cancer Gene Ther; 2004 Mar; 11(3):208-14. PubMed ID: 14671673 [TBL] [Abstract][Full Text] [Related]
6. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor. Manome Y; Watanabe M; Abe T; Tomita M; Watanabe S; Yokokawa Y; Takahashi Y; Ishii K; Kimura A; Murakami M; Nagata M; Shibata T; Nakamura M; Tanigawa N; Ohno T Anticancer Res; 2001; 21(4A):2265-72. PubMed ID: 11724281 [TBL] [Abstract][Full Text] [Related]
7. Genetic prodrug activation therapy (GPAT) in two rat prostate models generates an immune bystander effect and can be monitored by magnetic resonance techniques. Eaton JD; Perry MJ; Todryk SM; Mazucco RA; Kirby RS; Griffiths JR; Dalgleish AG Gene Ther; 2001 Apr; 8(7):557-67. PubMed ID: 11319623 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy. Xie Y; Gilbert JD; Kim JH; Freytag SO Clin Cancer Res; 1999 Dec; 5(12):4224-32. PubMed ID: 10632364 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and the bystander effect in CD::UPRT/5-FC bi-gene therapy of glioma. Shi DZ; Hu WX; Li LX; Chen G; Wei D; Gu PY Chin Med J (Engl); 2009 Jun; 122(11):1267-72. PubMed ID: 19567135 [TBL] [Abstract][Full Text] [Related]
10. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter]. Kong BH; Song Y; Ma DX; Qu X; Jiang S Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323 [TBL] [Abstract][Full Text] [Related]
11. Intratumoral 5-fluorouracil produced by cytosine deaminase/5-fluorocytosine gene therapy is effective for experimental human glioblastomas. Miller CR; Williams CR; Buchsbaum DJ; Gillespie GY Cancer Res; 2002 Feb; 62(3):773-80. PubMed ID: 11830532 [TBL] [Abstract][Full Text] [Related]
12. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene. Kim JH; Kolozsvary A; Rogulski K; Khil MS; Brown SL; Freytag SO Cancer J Sci Am; 1998; 4(6):364-9. PubMed ID: 9853135 [TBL] [Abstract][Full Text] [Related]
13. [Toxic effects of HSV-TK and CD-TK suicidal gene systems on prostate carcinoma cells]. Zhang DQ; Xu CX; Xu ZS; Ma DX; Zhang HQ; Liu CS Ai Zheng; 2003 Aug; 22(8):812-5. PubMed ID: 12917025 [TBL] [Abstract][Full Text] [Related]
14. [Bystander effect mediated by herpes simplex virus-thymidine kinase/ganciclovir approach on prostatic cancer cells and its regulation]. Xing Y; Lu G; Xiao Y; Zeng F; Zhang Q; Xiong P; Feng W Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1484-7. PubMed ID: 12509912 [TBL] [Abstract][Full Text] [Related]
15. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo. Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094 [TBL] [Abstract][Full Text] [Related]
16. Adenoviral-mediated transfer of a heat-inducible double suicide gene into prostate carcinoma cells. Blackburn RV; Galoforo SS; Corry PM; Lee YJ Cancer Res; 1998 Apr; 58(7):1358-62. PubMed ID: 9537229 [TBL] [Abstract][Full Text] [Related]
17. Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine. Haberkorn U; Oberdorfer F; Gebert J; Morr I; Haack K; Weber K; Lindauer M; van Kaick G; Schackert HK J Nucl Med; 1996 Jan; 37(1):87-94. PubMed ID: 8544010 [TBL] [Abstract][Full Text] [Related]
18. Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil. Kuriyama S; Masui K; Sakamoto T; Nakatani T; Kikukawa M; Tsujinoue H; Mitoro A; Yamazaki M; Yoshiji H; Fukui H; Ikenaka K; Mullen CA; Tsujii T Anticancer Res; 1998; 18(5A):3399-406. PubMed ID: 9858915 [TBL] [Abstract][Full Text] [Related]
19. [Antitumor effects of cytosine deaminase and HSV-tk double suicide gene with adenovirus mediation on rectal cancer cells]. Li S; Yu B; An P Zhonghua Wai Ke Za Zhi; 2001 Aug; 39(8):577-9. PubMed ID: 11758189 [TBL] [Abstract][Full Text] [Related]
20. Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy. Frank S; Steffens S; Fischer U; Tlolko A; Rainov NG; Kramm CM Cancer Gene Ther; 2002 Feb; 9(2):178-88. PubMed ID: 11857036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]